Quantcast
Last updated on April 17, 2014 at 11:16 EDT

Latest bladder cancer Stories

2014-02-04 12:27:33

Study shows that in 95% of cases CellDetect(TM) distinguished staining and succeeded in identifying the cancerous cells TEL AVIV, Israel, Feb. 4, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, has expanded its...

2014-01-30 23:03:55

In the second whole-genome sequencing study ever conducted in bladder cancer, a Roswell Park-led team observed two distinct patterns of aberrations, and identified a potential target for therapy. Buffalo, NY (PRWEB) January 30, 2014 In the first whole-genome analysis conducted through the Roswell Park Cancer Institute (RPCI) Center for Personalized Medicine, researchers report that invasive bladder cancers demonstrate two distinct patterns of genetic alteration, one of which may result...

2014-01-30 12:28:48

International studies demonstrate importance of comprehensive tumor profiling for poor-prognosis cancer patients IRVING, Texas, Jan. 30, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present two tumor profiling studies at the 2014 Genitourinary Cancers Symposium held this week in San Francisco, Calif. Through use of the company's comprehensive tumor profiling service, Caris Molecular Intelligence,...

2014-01-29 23:29:07

Schlichter, Bogard & Denton, LLP is investigating and pursuing claims on behalf of individuals who allege that they have been diagnosed with bladder cancer after taking the diabetes medication Actos® for more than one year. St. Louis, MO (PRWEB) January 29, 2014 The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation, MDL 2299, begins on Monday, January 27, 2014 with opening statements expected to occur on February 3, 2014....

2014-01-28 23:00:18

First Actos bellwether trial is underway, with the jury having been selected on Monday. Thousands of Plaintiffs in the Actos litigation developed bladder cancer, allegedly because of Actos (pioglitazone). New York, New York (PRWEB) January 28, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports that the first Actos bellwether trial has commenced. According to court documents, the jury was...

2014-01-26 23:02:18

The Firm is representing clients in Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused bladder cancer. New Yor, New York (PRWEB) January 26, 2014 Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) alleging long-term use of the Type 2 diabetes drug can cause bladder cancer continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports....

2014-01-24 23:22:03

Flood Law Group to Review Claims on Behalf of People Who Have Taken Actos and Also Had Bladder Cancer Washington, DC (PRWEB) January 24, 2014 With bellwether trial dates approaching, the nationally respected personal injury litigation firm Flood Law Group, LLP is now available to investigate potential Actos lawsuits on behalf of patients who have taken Actos and who been diagnosed with bladder cancer. Actos is a prescription drug used to treat diabetes and has seen widespread use in the...

2014-01-19 23:03:35

Results from the third case in Nevada clearing Takeda of liability (A-12-655741-C, Clark County District Court, NV) has prompted LawsuitLegal.com to offer online legal reviews for alleged victims seeking more information. Las Vegas, NV (PRWEB) January 19, 2014 The recent conclusion of the third bellweather legal case against Takeda Pharmaceuticals Inc., makers of Actos, resulted in a victory for the defendent, clearing Takeda of any liability. Prompted by the finding, LawsuitLegal.com is...

2014-01-19 23:01:25

The Firm is evaluating Actos lawsuits on behalf of long-term users of the drug who have been diagnosed with bladder cancer. New York, New York (PRWEB) January 19, 2014 Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) that allege long-term use of the Type II diabetes drug caused patients to develop bladder cancer continue to mount in the federal multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP...

2014-01-18 23:01:32

MarketOptimizer.org adds latest report on “OpportunityAnalyzer: Bladder Cancer – Opportunity Analysis and Forecasts to 2017” to its store. Dallas, TX (PRWEB) January 18, 2014 Despite the launch of Spectrum Pharmaceuticals’ EOquin, Nominal Growth in US and EU Bladder Cancer Market is expected from 2012 to 2017. This report estimates the bladder cancer market in the US and 5EU (France, Germany, Italy, Spain, and UK) in 2012 to be valued at $239.3m. This market is defined as the...